Search results
Results From The WOW.Com Content Network
In R&D, leadership changed for the first time in 15 years, ... Price Action: PFE stock is down 1.49% at $26.40 at the last check on Tuesday. Read Next:
In 1881, Pfizer moved its administrative headquarters to 81 Maiden Lane in Manhattan, presaging the company's expansion to Chicago, Illinois a year later. [ 6 ] [ 8 ] By 1906 sales exceeded $3 million.
Here is whether Pfizer stock might be a buy today -- and why. Pfizer's pandemic boom (and bust) shouldn't haunt the stock much longer. Dividend investors will focus on Pfizer's current dividend ...
Pharmacia & Upjohn was a global pharmaceutical company formed by the merger of Sweden-based Pharmacia AB and the American company Upjohn in 1995. [1] Today the remainder of the company is owned by Pfizer.
The company was owned by Pfizer from 2002 until 2020. In 2015, Pfizer resurrected the Upjohn brand name for a division which manufactures and licenses drugs with patents that have expired. As of 2019, Pfizer planned to divest itself of this business in 2020. [6] In July 2019, Pfizer announced plans to merge Upjohn with Mylan. [7]
PFE data by YCharts. More importantly, revenue and earnings bottomed and began rising again this year. This isn't a fluke; through nine months of 2024, Pfizer's specialty care products are up 11% ...
PFE Revenue (TTM) data by YCharts Pfizer's vaccine (Comirnaty) and treatment option (Paxlovid) combined for $56 billion in revenue in 2022. Those two products represented just $2.4 billion of ...
Given how well Pfizer has performed in recent years due to its COVID-19 vaccine and pill (its revenue topped $100 billion in 2022), for many investors, it's still seen as a stock whose best days ...